0: The present study has been approved by the Regional Ethical Review Board in Uppsala, Sweden (Dnr 2016/230/2) and registered in ClinicalTrials.gov (NCT04586517), registered on 14 October, 2020.
1: The study will be performed in accordance with the Declaration of Helsinki and written informed consent according to GDPR guidelines will be obtained from the participants.
2: Collections of biological material as blood and tissue samples will be stored according to the Regional Biobank in Uppsala.
3: Results will be disseminated through presentations at scientific meetings, publications in peer-reviewed journals, social media, and patient organizations.
4: A data sharing plan has been established, where de-identified individual data on participant characteristics and main study outcomes will be made available on reasonable request once the results are published.
